Denver PWM’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Denver PWM's BMY Position: Q1 2026 in Review
Denver PWM reduced its Bristol-Myers Squibb (BMY) stake by 7.2% in Q1 2026, selling an estimated $29.1K and leaving 6,400 shares worth $359K. The position accounts for 0.12% of the portfolio, ranked #67.
Denver PWM first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $375K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Denver PWM held 6,400 shares of Bristol-Myers Squibb worth $359K as of Q1 2026.
- Denver PWM sold 500 Bristol-Myers Squibb shares in Q1 2026, an estimated $29.1K.
- Bristol-Myers Squibb made up 0.12% of Denver PWM's portfolio in Q1 2026, its #67 holding.
- Denver PWM first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- Denver PWM's Bristol-Myers Squibb position peaked at $375K in Q1 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Denver PWM's 13F filing for Q1 2026, filed 13 May 2026.